Pfizer Inc on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment for 2023, intensifying investor concerns over demand for the products. Go to Source January 31, 2023 – 9:03 pm / Twitter: @hoffeldtcom